| Engineering cells with intracellular agent–loaded microparticles to control cell phenotype JA Ankrum, OR Miranda, KS Ng, D Sarkar, C Xu, JM Karp Nature protocols 9 (2), 233-245, 2014 | 110 | 2014 |
| Generating iPSCs: Translating Cell Reprogramming Science into Scalable and Robust Biomanufacturing Strategies M Silva, L Daheron, H Hurley, K Bure, R Barker, AJ Carr, D Williams, ... Cell stem cell 16 (1), 13-17, 2015 | 73 | 2015 |
| Emerging medical devices for minimally invasive cell therapy ED O'Cearbhaill, KS Ng, JM Karp Mayo Clinic Proceedings 89 (2), 259-273, 2014 | 60 | 2014 |
| Triggered drug release from dynamic microspheres via a protein conformational change WJ King, NJ Pytel, K Ng, WL Murphy Macromolecular bioscience 10 (6), 580-584, 2010 | 38 | 2010 |
| Beyond hit-and-run: stem cells leave a lasting memory KS Ng, TM Kuncewicz, JM Karp Cell metabolism 22 (4), 541-543, 2015 | 34 | 2015 |
| Tetrandrine identified in a small molecule screen to activate mesenchymal stem cells for enhanced immunomodulation Z Yang, J Concannon, KS Ng, K Seyb, LJ Mortensen, S Ranganath, F Gu, ... Scientific Reports 6, 30263, 2016 | 33 | 2016 |
| Extracellular Vesicles Commercial Potential As Byproducts of Cell Manufacturing for Research and Therapeutic Use JA Smith, KS Ng, BE Mead, S Dopson, B Reeve, J Edwards, MJA Wood, ... BioProcess International, 0 | 21* | |
